Juan Diaz, Panama Clinical Trials

A listing of Juan Diaz, Panama clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 18 clinical trials
VenTouch OUS Feasibility Study

This is a prospective, multi-center, single-arm study to evaluate safety and efficacy of the VenTouch System for treatment of subjects with functional MR.

Pacifica Salud Hospital Punta Pacifica
 (6.9 away) Contact site
  • 5 views
  • 25 Jan, 2021
  • +14 other locations
CPNS Pilot Study: Evaluation of Safety and Performance of the Cardiac Pulmonary Nerve Stimulation (CPNS) System in Patients With ADHF

The CPNS Pilot Study: An evaluation of the safety and performance of the Cardionomic Cardiac Pulmonary Nerve Stimulation (CPNS) system in patients with acute decompensated heart failure.

Punta Pacifica
 (6.9 away) Contact site
  • 0 views
  • 23 Sep, 2021
  • +5 other locations
The Effect of Higher Protein Dosing in Critically Ill Patients

The investigator will investigate the effects of higher protein/amino acid dosing (2.2 g/kg/d) vs usual protein/amino acid dosing (1.2 g/kg/d) on clinical outcomes in nutritionally high risk ill patients.

severe malnutrition
sarcopenia
amino acids
Complejo Hospitalario Dr. Arnulfo Arias Madrid de la Caja de Seguro Social
 (5.9 away) Contact site
  • 123 views
  • 02 Jul, 2021
  • +93 other locations
Safety Tolerability and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Patients

To assess the safety, tolerability, and pharmacokinetics (PK) of cefiderocol after single-dose administration in hospitalized pediatric patients 3 months to < 12 years of age with suspected or confirmed aerobic Gram-negative bacterial infections and after multiple-dose administration in hospitalized pediatric patients 3 months to < 18 years of age with …

renal function
antibiotics
pneumonia
Hospital de Especialidades Ped Via Espa a y Calle Zarak
 (6.9 away) Contact site
  • 2 views
  • 07 Aug, 2021
  • +20 other locations
A Study in Infants With RSV LRTI to Evaluate RV521

This is a multicentre, 3-part study to evaluate safety, tolerability, PK, PD, and antiviral effect of single and multiple dosing of RV521 in infants hospitalised due to Respiratory Syncytial Virus (RSV) lower respiratory tract infection (LRTI). Due to the adaptive study design, the number of enrolled subjects may vary depending …

antiviral
respiratory tract infection
Reviral Site 3201
 (6.9 away) Contact site
  • 31 views
  • 24 Jan, 2021
  • +67 other locations
Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease

The goal of the study is to compare the efficacy and safety of crizanlizumab + standard of care to standard of care alone on renal function in sickle cell disease patients 16 years with chronic kidney disease due to sickle cell nephropathy.

absolute neutrophil count
hydroxyurea
conjugated bilirubin
thal
Novartis Investigative Site
 (6.9 away) Contact site
  • 7 views
  • 24 Sep, 2021
  • +30 other locations
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A

The primary purpose of the study is to compare the efficacy and safety of canakinumab versus placebo as adjuvant therapy in adult subjects with stages AJCC/UICC v. 8 II -IIIA and the subset of IIIB (T>5cm N2 disease) completely resected (R0) non-small cell lung cancer (NSCLC).

lung carcinoma
systemic therapy
alopecia
Novartis Investigative Site
 (6.9 away) Contact site
  • 645 views
  • 21 Sep, 2021
  • +416 other locations
Study Evaluating Pharmacokinetics (PK) Safety and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in HIV-1 Infected Virologically Suppressed Pediatric Participants

Cohort 1: The primary objectives are: To evaluate the steady-state pharmacokinetics (PK) of Atazanavir (ATV) and Darunavir (DRV) and confirm the dose of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co) in HIV-1 infected, virologically suppressed adolescent participants weighing 25 kg (12 to < 18 years of age) To evaluate the …

ritonavir
antiretroviral agents
darunavir
antiretroviral
tuberculosis
Hopital del Nino
 (6.9 away) Contact site
  • 236 views
  • 21 Aug, 2021
  • +40 other locations
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

This is an event driven Phase 3, prospective, randomized, open-label, blinded endpoint evaluation (PROBE) parallel group study in subjects with confirmed VTE. This study is designed to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of edoxaban and to compare the efficacy and safety of edoxaban against standard of care in …

edoxaban
anticoagulant therapy
anticoagulants
probe
thromboembolism
Indicasat Aip
 (6.9 away) Contact site
  • 0 views
  • 28 Jan, 2021
  • +169 other locations
Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children Known or Suspected to be Caused by Susceptible Gram-positive Organisms Including MRSA

To determine the safety and descriptive efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections in children, aged birth to 17 years (inclusive), known or suspected to be caused by susceptible Gram-positive organisms, including methicillin-resistant strains of Staphylococcus aureus.

vancomycin
leukopenia
fluctuance
cellulitis
platelet count
Hospital Del Ni o Dr. Jos Ren n Esquivel
 (6.9 away) Contact site
  • 0 views
  • 24 Jan, 2021
  • +95 other locations